Please login to the form below

Not currently logged in
Email:
Password:

Redx names former Bayer exec as chairman

Frank Armstrong brings decades of experience to infectious disease biotech

Frank Armstrong, RedxRedx Pharma has appointed Dr Frank Armstrong as non-executive chairman.

Dr Armstrong has decades of experience in the pharma industry, including spells as executive VP and head of worldwide product development at Bayer and head of medical science and innovation at Merck Serono.

More recently he has worked as an independent consultant for pharma and biotech companies as well as serving on several company boards and these include current chairman positions at CardioRentis, Summit PLC and Xceleron.

He will now help guide Redx as it advances its research efforts into infectious diseases and cancer.

Dr Peter Jackson, co-founder and director at Redx, said: “[Frank's] pharma business experience and clinical insight will make a valuable contribution to our plans for further growth and he is extremely well networked internationally.”

To date this growth includes the creation of a research centre at AstraZeneca's (AZ) former site in Alderley Park, Cheshire in the UK.

Redx is also working with AZ and this week announced the two companies had signed a collaboration to research the genetic drivers of tumour growth.

4th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics